HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease.

Abstract
TV3326, [(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate] is a novel aminoindan derivative of the selective irreversible monoamine oxidase (MAO)-B inhibitor, rasagiline (N-propargyl-(1R)-aminoindan), possessing both cholinesterase (ChE) and MAO-inhibitory activity. In doses of 35-100 micromoles/kg administered orally to rats, it inhibits ChE by 25-40% and antagonises scopolamine-induced impairments in spatial memory. After daily administration of 75 micromoles/kg for 2 weeks, TV3326 does not show any motor stimulant effects but significantly reduces immobility in the forced swim test, an action consistent with that of known antidepressants. This could result from more than 70% inhibition of both MAO-A and B in the brain that occurs under these conditions, since it is not shared by the S-isomer, TV3279, which does not block MAO. TV3326 also shows selectivity for brain MAO, even after 2 months of daily administration, with little or no effect on the enzyme in the intestinal tract and liver. This reduces the likelihood of it producing the "cheese effect" if administered with tyramine-containing foods or beverages. TV3326 and TV3279 protect against ischemia-induced cytotoxicity in PC12 cells and reduce the oedema, deficits in motor function and memory after closed head injury in mice. These neuroprotective effects do not result from MAO inhibition. The pharmacological actions of TV3326 could be of clinical importance for the treatment of AD, and the drug is currently in development for this purpose.
AuthorsM Weinstock, C Bejar, R H Wang, T Poltyrev, A Gross, J P Finberg, M B Youdim
JournalJournal of neural transmission. Supplementum (J Neural Transm Suppl) Issue 60 Pg. 157-69 ( 2000) ISSN: 0303-6995 [Print] Austria
PMID11205137 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • (N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate
  • Cholinesterase Inhibitors
  • Indans
  • Monoamine Oxidase Inhibitors
  • Neuroprotective Agents
  • rasagiline
  • Scopolamine
  • Monoamine Oxidase
  • Acetylcholinesterase
Topics
  • Acetylcholinesterase (drug effects, metabolism)
  • Alzheimer Disease (drug therapy, enzymology, physiopathology)
  • Animals
  • Brain Injuries (complications, drug therapy)
  • Cholinesterase Inhibitors (pharmacology)
  • Indans (agonists, pharmacology)
  • Male
  • Memory Disorders (chemically induced, drug therapy)
  • Monoamine Oxidase (drug effects, metabolism)
  • Monoamine Oxidase Inhibitors (pharmacology)
  • Motor Activity (drug effects, physiology)
  • Neuroprotective Agents (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Scopolamine (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: